1378652-03-9 Usage
Pyridine derivative
It belongs to the class of pyridine derivatives, which are compounds that are structurally related to pyridine, a six-membered aromatic heterocyclic compound.
Pyrazole and pyridine rings
The compound contains a pyrazole ring fused to a pyridine ring, which contributes to its unique structure and potential biological activities.
Carbonitrile group
A carbonitrile group (C≡N) is attached at the 4-position of the pyridine ring, which can serve as a versatile functional group for further modification and optimization of the compound's properties.
Potential applications
1H-pyrazolo[3,4-b]pyridine-4-carbonitrile has potential applications in the pharmaceutical and agrochemical industries due to its unique structure and potential biological activities.
Building block
The compound may be used as a building block in the synthesis of various heterocyclic compounds and drug molecules.
Safety precautions
As with any chemical, proper handling and safety precautions should be followed when working with 1H-pyrazolo[3,4-b]pyridine-4-carbonitrile.
Check Digit Verification of cas no
The CAS Registry Mumber 1378652-03-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,8,6,5 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1378652-03:
(9*1)+(8*3)+(7*7)+(6*8)+(5*6)+(4*5)+(3*2)+(2*0)+(1*3)=189
189 % 10 = 9
So 1378652-03-9 is a valid CAS Registry Number.
1378652-03-9Relevant academic research and scientific papers
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
-
Paragraph 0283, (2015/12/24)
The present application provides a compound of formula (I) and/or a salt thereof, wherein R1, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disor
COMPOUNDS AND METHODS OF USE
-
Page/Page column 128-129, (2010/11/27)
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
